Dental Care Clinics in Riverton, WY Accepting Medicare
9 Dental Care Clinics found. Showing 1 - 9
 Dr. Josh Fowler, Dmd, Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 621 N 8th St W, Riverton, WY 82501 Phone: 307-856-9725 Fax: 307-856-7075 |
Riverton Dental Center Pc Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 325 W Main, #g, Riverton, WY 82501 Phone: 307-856-8660 |
Oak Haven Dental Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 203 E Main St, Suite 205, Riverton, WY 82501 Phone: 307-857-2020 Fax: 307-857-2727 |
Dental Care Of Fremont County Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1224 E Jackson Ave, Riverton, WY 82501 Phone: 307-856-3463 Fax: 307-856-9910 |
Rendezvous Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 831 W Sunset Dr, Riverton, WY 82501 Phone: 307-856-2778 Fax: 307-856-6572 |
Riverton Smiles Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 1224 East Jackson Ave, Riverton, WY 82501 Phone: 307-856-3463 Fax: 307-856-9910 |
Graham Family Dental Clinic/Center - Dental Medicare: Not Enrolled in Medicare Practice Location: 325 W Main St Ste G, Riverton, WY 82501 Phone: 307-856-5210 |
Moss Dentistry Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 203 E Main Street, Suite 205, Riverton, WY 82501 Phone: 307-857-2020 Fax: 307-857-2727 |
Benchmark Dental, Pc Dentist Medicare: Not Enrolled in Medicare Practice Location: 621 N 8th St W, Riverton, WY 82501 Phone: 307-856-9725 Fax: 307-856-7075 |
News Archive
Genetic breakthrough in tracing the cause of a rare kidney and liver disorder
Birmingham scientists have made a genetic breakthrough in tracing the cause of a rare kidney and liver disorder. ARC syndrome means babies are born with impairment to kidney and liver function, bleeding problems and weak muscles. This usually leads to early death. The gene which causes this condition has been identified.
FDA approves Rebiotix's IND application to begin RBX2660 Phase 2 study for recurrent CDI
Rebiotix Inc. announced today that the U.S. Food and Drug Administration has approved the company's Investigational New Drug application to begin the Phase 2 clinical study of RBX2660 for the treatment of recurrent Clostridium difficile infection.
New test methods with less fear
It is a principle of modern architecture that less may be more. This principle does not apply to information as a basis of far-reaching decisions, it seems.
New study encourages pediatricians to treat the cause, not the symptoms
​Researchers at Holland Bloorview Kids Rehabilitation Hospital have found that more than 25 percent of children with cerebral palsy seen by physicians have moderate to severe chronic pain, limiting their activity. Findings indicate that pediatricians should be aware of chronic pain in this group and try to identify and treat its underlying causes.
Improving tuberculosis (TB) diagnosis: an interview with Professor Madhukar Pai, MD, PhD
TB is an infectious disease caused by Mycobacterium tuberculosis. Nearly 9 million people develop TB every year, and TB kills nearly 1.4 million individuals each year. While the incidence of TB has steadily declined in the west, it remains a huge public health problem in many developing countries, with India having the highest burden.
› Verified 2 days ago